Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

113 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Boosted lopinavir- versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: a prospective study of HIV-infected individuals in high-income countries.
HIV-CAUSAL Collaboration; Cain LE, Phillips A, Olson A, Sabin C, Jose S, Justice A, Tate J, Logan R, Robins JM, Sterne JA, van Sighem A, Reiss P, Young J, Fehr J, Touloumi G, Paparizos V, Esteve A, Casabona J, Monge S, Moreno S, Seng R, Meyer L, Pérez-Hoyos S, Muga R, Dabis F, Vandenhende MA, Abgrall S, Costagliola D, Hernán MA. HIV-CAUSAL Collaboration, et al. Among authors: paparizos v. Clin Infect Dis. 2015 Apr 15;60(8):1262-8. doi: 10.1093/cid/ciu1167. Epub 2015 Jan 6. Clin Infect Dis. 2015. PMID: 25567330 Free PMC article.
Impact of antiretroviral therapy on tuberculosis incidence among HIV-positive patients in high-income countries.
del Amo J, Moreno S, Bucher HC, Furrer H, Logan R, Sterne J, Pérez-Hoyos S, Jarrín I, Phillips A, Lodi S, van Sighem A, de Wolf W, Sabin C, Bansi L, Justice A, Goulet J, Miró JM, Ferrer E, Meyer L, Seng R, Toulomi G, Gargalianos P, Costagliola D, Abgrall S, Hernán MA; HIV-CAUSAL Collaboration. del Amo J, et al. Clin Infect Dis. 2012 May;54(9):1364-72. doi: 10.1093/cid/cis203. Epub 2012 Mar 28. Clin Infect Dis. 2012. PMID: 22460971 Free PMC article.
HIV cascade of care in Greece: Useful insights from additional stages.
Vourli G, Nikolopoulos G, Paparizos V, Skoutelis A, Metallidis S, Gargalianos P, Papadopoulos A, Chini M, Sipsas NV, Psychogiou M, Chrysos G, Sambatakou H, Gogos C, Katsarou O, Paraskeva D, Dedes N, Touloumi G; Greek HIV Prevention Group. Vourli G, et al. Among authors: paparizos v. PLoS One. 2018 Nov 15;13(11):e0207355. doi: 10.1371/journal.pone.0207355. eCollection 2018. PLoS One. 2018. PMID: 30440000 Free PMC article. Clinical Trial.
Long-term evolution of CD4+ cell count in patients under combined antiretroviral therapy.
Pantazis N, Papastamopoulos V, Paparizos V, Metallidis S, Adamis G, Antoniadou A, Psichogiou M, Chini M, Sambatakou H, Sipsas NV, Gogos C, Chrysos G, Panagopoulos P, Katsarou O, Gikas A, Touloumi G; AMACS. Pantazis N, et al. Among authors: paparizos v. AIDS. 2019 Aug 1;33(10):1645-1655. doi: 10.1097/QAD.0000000000002248. AIDS. 2019. PMID: 31305332
Cardiovascular risk factors in HIV infected individuals: Comparison with general adult control population in Greece.
Touloumi G, Kalpourtzi N, Papastamopoulos V, Paparizos V, Adamis G, Antoniadou A, Chini M, Karakosta A, Makrilakis K, Gavana M, Vantarakis A, Psichogiou M, Metallidis S, Sipsas NV, Sambatakou H, Hadjichristodoulou C, Voulgari PV, Chrysos G, Gogos C, Chlouverakis G, Tripsianis G, Alamanos Y, Stergiou G; AMACS and EMENO. Touloumi G, et al. Among authors: paparizos v. PLoS One. 2020 Mar 30;15(3):e0230730. doi: 10.1371/journal.pone.0230730. eCollection 2020. PLoS One. 2020. PMID: 32226048 Free PMC article.
HIV continuum of care: bridging cross-sectional and longitudinal analyses.
Touloumi G, Thomadakis C, Pantazis N, Papastamopoulos V, Paparizos V, Metallidis S, Adamis G, Chini M, Psichogiou M, Chrysos G, Sambatakou H, Barbunakis E, Vourli G, Antoniadou A; on behalf of the AMACS. Touloumi G, et al. Among authors: paparizos v. AIDS. 2022 Mar 15;36(4):583-591. doi: 10.1097/QAD.0000000000003131. AIDS. 2022. PMID: 34772850
Changes in Body Mass Index after Initiation of Antiretroviral Treatment: Differences by Class of Core Drug.
Pantazis N, Papastamopoulos V, Antoniadou A, Adamis G, Paparizos V, Metallidis S, Sambatakou H, Psichogiou M, Chini M, Chrysos G, Panagopoulos P, Sipsas NV, Barbunakis E, Gogos C, Touloumi G; Athens Multicenter AIDS Cohort Study (AMACS). Pantazis N, et al. Among authors: paparizos v. Viruses. 2022 Jul 29;14(8):1677. doi: 10.3390/v14081677. Viruses. 2022. PMID: 36016299 Free PMC article.
Low pre-ART CD4 count is associated with increased risk of clinical progression or death even after reaching 500 CD4 cells/μL on ART.
Pantazis N, Paparizos V, Papastamopoulos V, Metallidis S, Antoniadou A, Adamis G, Psichgiou M, Chini M, Sambatakou H, Chrysos G, Sipsas NV, Gogos C, Barbunakis E, Panagopoulos P, Katsarou O, Touloumi G; Athens Multicenter AIDS Cohort Study (AMACS). Pantazis N, et al. Among authors: paparizos v. PLoS One. 2023 Mar 30;18(3):e0283648. doi: 10.1371/journal.pone.0283648. eCollection 2023. PLoS One. 2023. PMID: 36996018 Free PMC article.
113 results